How to preserve potency and continence in localized prostate cancer.
Breda
Guglielmo
G
Department of Urology, San Bassiano Hospital, Bassano del Grappa, Italy. guglielmo.breda@aslbassano.it
Celia
Antonio
A
D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use; D001918:Brachytherapy / Q000009:adverse effects; D002983:Clinical Competence; D007172:Erectile Dysfunction / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control; D011468:Prostatectomy / Q000009:adverse effects / Q000379:methods; D011471:Prostatic Neoplasms / Q000628:therapy*; D014549:Urinary Incontinence / Q000517:prevention & control*
D018931:Antineoplastic Agents, Hormonal